Ilesol Pharmaceuticals has finished with the project planning and documentation for the production of cannabinoid API’s.

We have the potential to broaden our scope to  the production of cannabinoid generic drugs as well as the development of new drugs.

Our present businesses in the Food supplement and Cosmetic sectors  offer  investment opportunities.

If you are interested in becoming a part of our projects or investing in our company, do not hesitate to contact us.


This site is registered on as a development site.